New Strong Buy Stocks for March 23rd

06:50am, Monday, 23'rd Mar 2026
LCUT, EFXT, MGA, ADMA and JLL have been added to the Zacks Rank #1 (Strong Buy) List on March 23, 2026.
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $15.02, denoting a +1.01% move from the preceding trading day.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
B Group Inc. grew its stake in ADMA Biologics Inc (NASDAQ: ADMA) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned
Adma Biologics (ADMA) concluded the recent trading session at $15.15, signifying a +1.03% move from its prior day's close.
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
Adma Biologics (ADMA) reached $14.99 at the closing of the latest trading day, reflecting a -4.34% change compared to its last close.

Best Momentum Stocks to Buy for March 12th

11:01am, Thursday, 12'th Mar 2026
ADMA, RELY and HSY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 12th, 2026.

New Strong Buy Stocks for March 12th

06:26am, Thursday, 12'th Mar 2026
AEO, RELY, ADMA, HSY and HTBK have been added to the Zacks Rank #1 (Strong Buy) List on March 12th, 2026.
ADMA Biologics (NASDAQ: ADMA - Get Free Report) and Rezolute (NASDAQ: RZLT - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based o
Adma Biologics (ADMA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
ADMA posts 18% Q4 revenue growth as Asceniv drives record 2025 sales, with 2026 revenues seen topping $635M and margins set to expand.
ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE